- Home
- PRTS vs NRSN Comparison
PRTS vs NRSN Comparison
Compare PRTS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTS | NRSN |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 30.5M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRTS | NRSN |
|---|---|---|
| Price | $0.72 | $1.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $0.70 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 776.3K | 225.5K |
| Earning Date | 03-05-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $560,632,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.37 | $0.68 |
| 52 Week High | $1.36 | $2.60 |
Technical Indicators
Market Signals| Indicator | PRTS | NRSN |
|---|---|---|
| Relative Strength Index (RSI) | 76.99 | 55.58 |
| Support Level | $0.48 | $0.95 |
| Resistance Level | $0.59 | $1.06 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 87.15 | 76.60 |
Price Performance
Historical ComparisonAbout PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.